secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2026-01-29T23:59:59+00:00
Accession:  0001171843-26-000516
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 2.05, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience to close Holliston facility; expects $4M annual savings from 2028
--------------------------------------------------------------------------------

- Closes Holliston, MA plant; moves US production to Minneapolis, MN; some operations to Germany, Sweden, UK.
- Project Viking: ~$3M cost savings in 2027, ~$4M annual from 2028 from overhead reduction and SKU rationalization.
- Pre-tax restructuring charges estimated $3.4-4.4M, including non-cash asset write-offs of $0.6-0.7M.
- Consolidation substantially complete by first half 2027; Holliston stays operational through 2026 for continuity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184326000516/0001171843-26-000516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184326000516/f8k_012326.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-000516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer